AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in these therapy areas - Oncology, Cardiovascular, Renal and Metabolism, and Respiratory. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Our Malaysia marketing company- AstraZeneca Malaysia Sdn Bhd, was established in 1981 and in 2019, the company announced a commitment to invest more than RM500 million (USD125m) in Malaysia over the next five years demonstrating a strengthening commitment towards patients, innovation and talent development in the country and rolling out new robotic and cognitive technology designed to improve efficiency and drive productivity across the Company’s global operations.

The investment included a new AstraZeneca Malaysia headquarters in Nucleus Tower, Mutiara Damansara which is part of Greater Kuala Lumpur, housing local and global business operations across a wide variety of functions, such as finance and procurement leadership for the region. This is part of AstraZeneca’s ongoing commitment to boost high-value skills and employment, and in bringing new science and innovation to help patients.

In addition, a new Global Business Services hub will be equipped with cutting-edge robotic technology and automation to support financial, accounting and business services for AstraZeneca operations in the Asia Pacific region. The Robotic and Cognitive Centre will deliver ‘digital disruption’ in day-to-day operations, bringing greater efficiency and improving productivity that will be scaled across global operations using Robotic Process Automation, mimicking human actions by performing repetitive rules-based tasks across multiple applications.

The hub is one of AstraZeneca’s three shared services hubs globally, including in Costa Rica and Poland, and builds on the growth of the global business services sector in Malaysia, valued at USD240 billion in the Asia Pacific in 20141.

The AstraZeneca office currently hosts both the Marketing Company as well as the Global Business Services whom in total employs approximately 500 Malaysians.

AstraZeneca Malaysia marketing company’s vision is to push the boundaries of science to deliver life-changing medicines that addresses unmet medical needs in non-communicable diseases such as Cardiovascular, Diabetes, Renal Diseases and Cancer as well as Respiratory Illnesses.

We are aiming to treat, prevent, modify and in the future, even cure. It is only by enhancing our understanding of disease biology and uncovering new ways of targeting the drivers of disease that we will create the next generation of therapeutics across our main therapy areas.

We are already leveraging the rapid advancements in science and technology to create new therapeutics for disease mechanisms which were previously considered difficult, if not impossible, to target. Each new insight and every new piece of information brings us closer to creating better, more advanced and more effective treatments for patients.

Beyond accelerating our innovative pipeline to patients, AstraZeneca Malaysia partners with local stakeholders in Malaysia to increase healthcare access, stimulate innovation and improve outcomes through ‘beyond the pill’ approaches.